Method of treating vulvar dystrophy and vaginal dryness

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3120

Patent

active

053807570

ABSTRACT:
Gamma-linolenic (GLA) and/or dihomo-gamma-linolenic acid (DGLA) may be used in the treatment of vulvar dystrophy and/or vaginal dryness. Other essential fatty acids of the n-6 or n-3 series may also be used in association with GLA and/or DGLA.

REFERENCES:
patent: 4681896 (1987-07-01), Horrobin
patent: 5059622 (1991-10-01), Sears
patent: 5145686 (1992-09-01), Horrobin et al.
Robinson; Can. Med. Assoc. J., vol. 140, No. 6, 1989; "Premenstrual Syndrome: Current Knowledge and Management"; pp. 605-611.
Bonacossa et al.; Prostaglandins, vol. 23, No. 1, 1982; "Effect of Corticosterone . . . "; pp. 113-128.
Ney; Med. Hypotheses, vol. 20, No. 2, Jun. 1986; "The Intravaginal Absorption of Male Generated Hormones and Their Possible Effect on Female Behaviour"; Abstract.
European Search Report, Sep. 1993.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method of treating vulvar dystrophy and vaginal dryness does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating vulvar dystrophy and vaginal dryness, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating vulvar dystrophy and vaginal dryness will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-850970

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.